Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy.

Lancet Gastroenterol Hepatol

Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Published: November 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492423PMC
http://dx.doi.org/10.1016/S2468-1253(22)00302-8DOI Listing

Publication Analysis

Top Keywords

decrease uptake
4
uptake sars-cov-2
4
sars-cov-2 vaccine
4
vaccine patients
4
patients inflammatory
4
inflammatory bowel
4
bowel disease
4
disease intravenous
4
intravenous biological
4
biological therapy
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!